Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood Cancer Journal

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Hematology

Show all topics

DOI

10.1038/s41408-024-01068-w

License

CC-BY

Other Formats

PDF